Scrip
Clinica
Scrip Regulatory Affairs
Scrip Clinical Research
AnimalPharm
Email ID
Password
Forgotten your password?
Sign me in automatically next time
Advanced Search
Home
Therapy Sector
Generics
Business
Policy & Regulation
Research & Development
International
Cancer
|
Cardiovascular
|
Infection
|
Metabolic
|
Musculoskeletal
|
CNS
|
Respiratory
|
Gastrointestinal
|
Other
|
Therapy Sector Stage - Other
About Us
Getting Started
Subscribe
Free Trial
Advertise
Awards
White Papers
Executive Briefing
Classifieds
Recruitment
JOB OF THE WEEK
Promote your vacancy here
SCRIP's ONLINE DIRECTORY
Classified ads
LATEST NEWS
Xiaflex for Dupuytren's positive in pilot using convenient multiple injections
08 September 2011
Positive top-line Phase IIb for Lipid Therapeutics' ulcerati...
Wall Street smiles on first US autologous aesthetic cell the...
Betanis, Tradjenta and Onbrez priced and set for launch in Japan
08 September 2011
Reduced quake-related costs boost Chugai's bottom line
28 July 2011
Janssen seeks FDA meeting to discuss Simponi complete response
26 July 2011
Tarsa plans 2011 oral calcitonin NDA
19 July 2011
>> More News...
DERMATOLOGICAL
Xiaflex for Dupuytren's positive in pilot using convenient multiple injections
08 September 2011
Clinuvel hopes to shine as photoprotective nears market
22 May 2009
Recycling in the pharmaceutical industry
05 May 2009
>> More Dermatological...
GENETIC
PhRMA reports record number of rare disease drug candidates under development
28 February 2011
Private investment round-up: December 2009
06 January 2010
PTC Therapeutics raises $50 million
24 December 2009
>> More Genetic...
INFLAMMATORY
Nitec's Lodotra cleared for EU approvals
07 January 2009
Private investment round-up: September 2008
15 October 2008
>> More Inflammatory...
REPRODUCTIVE / GENITOURINARY
J&J's abiraterone improves survival in first Phase III prostate cancer trial
10 September 2010
FDA approves Bayer's Mirena for menorrhagia
06 October 2009
QuatRx's Ophena positive in Phase III trial of postmenopausal vaginal atrophy
15 September 2009
>> More Reproductive / Genitourinary...
OPHTHALMOLOGICAL
InSite to raise $22M to advance PhIII pipeline including combo product for lid margin disease
14 July 2011
Allergan to pay $600 million settle US Botox probe;drops off-label suit
10 September 2010
GSK/Valeant file anti-epileptic retigabine in the US and the EU
03 November 2009
>> More Ophthalmological...
REFINE BY
COMPANY/ORGANISATION
NOVARTIS
PFIZER
GLAXOSMITHKLINE
ABBOTT
CONDITION
PSORIASIS
ACNE
CANCER
PAIN
GEOGRAPHY
CANADA
GERMANY
JAPAN
FRANCE
DRUG
ETANERCEPT
METHOTREXATE
ADALIMUMAB
CICLOSPORIN
